相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders - A Focus on the Modulation of Host Tissue Function
Simon A. Hirota
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation
Kaija-Leena Kolho et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome
Daniela Weber et al.
BLOOD (2015)
Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases
Jonathan J. Hansen
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases
Herbert L. DuPont
MAYO CLINIC PROCEEDINGS (2015)
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease
Ernst Holler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
Ying Taur et al.
BLOOD (2014)
The microbiome revolution
Martin J. Blaser
JOURNAL OF CLINICAL INVESTIGATION (2014)
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
Georgina L. Hold et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship
Jun Gao et al.
GUT MICROBES (2014)
Rifaximin for Preventing Acute Graft-Versus-Host Disease: Impact on Plasma Markers of Inflammation and T-cell Activation
Muna Qayed et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins
Yoshihiro Eriguchi et al.
BLOOD (2012)
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Robert R. Jenq et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Pregnane X receptor as a target for treatment of inflammatory bowel disorders
Jie Cheng et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles
Eric L. Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases
Hoonmo L. Koo et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei
Zhi-Dong Jiang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system
Simone Maccaferri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Rifaximin pharmacology and clinical implications
Veronica Ojetti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
C Prantera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
An open-label evaluation of rifaximin in the treatment of active Crohn's disease
I Shafran et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Rifaximin, a poorly absorbed antibiotic: Pharmacology and clinical potential
C Scarpignato et al.
CHEMOTHERAPY (2005)
Variations in 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation
M Kreutz et al.
BONE MARROW TRANSPLANTATION (2004)
分享论文
